PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy

PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy

Guardado en:
Detalles Bibliográficos
Autores principales: Min Li, Yiqi Xu, Yuqing Wang, Xuan Zhou, Mei Mei, Jingxuan Yang, Zhenyue Gao, Ruxin Hu, Yuhong Wang, Zheng Su, Xiaoyue Zhang, Yu Ren
Formato: article
Lenguaje:EN
Publicado: BMJ Publishing Group 2021
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/f250465286994ea6abf8effc519ed749
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f250465286994ea6abf8effc519ed749
record_format dspace
spelling oai:doaj.org-article:f250465286994ea6abf8effc519ed7492021-12-01T13:00:05ZPD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy10.1136/jitc-2021-0026992051-1426https://doaj.org/article/f250465286994ea6abf8effc519ed7492021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e002699.fullhttps://doaj.org/toc/2051-1426Min LiYiqi XuYuqing WangXuan ZhouMei MeiJingxuan YangZhenyue GaoRuxin HuYuhong WangZheng SuXiaoyue ZhangYu RenBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Min Li
Yiqi Xu
Yuqing Wang
Xuan Zhou
Mei Mei
Jingxuan Yang
Zhenyue Gao
Ruxin Hu
Yuhong Wang
Zheng Su
Xiaoyue Zhang
Yu Ren
PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
format article
author Min Li
Yiqi Xu
Yuqing Wang
Xuan Zhou
Mei Mei
Jingxuan Yang
Zhenyue Gao
Ruxin Hu
Yuhong Wang
Zheng Su
Xiaoyue Zhang
Yu Ren
author_facet Min Li
Yiqi Xu
Yuqing Wang
Xuan Zhou
Mei Mei
Jingxuan Yang
Zhenyue Gao
Ruxin Hu
Yuhong Wang
Zheng Su
Xiaoyue Zhang
Yu Ren
author_sort Min Li
title PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
title_short PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
title_full PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
title_fullStr PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
title_full_unstemmed PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
title_sort pd-l2 glycosylation promotes immune evasion and predicts anti-egfr efficacy
publisher BMJ Publishing Group
publishDate 2021
url https://doaj.org/article/f250465286994ea6abf8effc519ed749
work_keys_str_mv AT minli pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT yiqixu pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT yuqingwang pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT xuanzhou pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT meimei pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT jingxuanyang pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT zhenyuegao pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT ruxinhu pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT yuhongwang pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT zhengsu pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT xiaoyuezhang pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
AT yuren pdl2glycosylationpromotesimmuneevasionandpredictsantiegfrefficacy
_version_ 1718405210191167488

Ejemplares similares